Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus
Phase 2
Not yet recruiting
- Conditions
- Hypomagnesemia in Type 2 Diabetic Patients
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Pharmalyte Solutions LLC
- Target Recruit Count
- 200
- Registration Number
- NCT03567824
MLD10 in the Prevention of Migraine in Adults
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Pharmalyte Solutions LLC
- Target Recruit Count
- 157
- Registration Number
- NCT02322333
- Locations
- 🇺🇸
The Research Center of Southern California, Carlsbad, California, United States
🇺🇸San Francisco Clinical Research Center, San Francisco, California, United States
🇺🇸Physician Associates of Florida Research Department, Oviedo, Florida, United States
News
No news found